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We  read with the interest with the work by Dr Kaneko and
olleagues that revealed the “obesity-mortality paradox” among
apanese patients with coronary artery disease undergoing per-
utaneous coronary artery intervention (PCI) between 2004 and
010 [1]. As we know, previous reports observed that the obesity-
ortality paradox was mainly present in patients receiving PCI in
hort-term results. In contrast, some reports raised a controversy
ith regard to the long-term impact of body mass index (BMI)
n mortality. Accordingly, we made a meta-analysis and found
 J-shaped relationship between BMI  and total mortality among
atients with PCI followed up for longer than 5 years [2]. We
ound that the long-term neutralized risk in total mortality for
he obesity category (BMI ≥ 30 kg/m2) may  result from increased
ardiac mortality. Moreover, there was relatively lower long-term
isk of myocardial infarction in obese patients, and the excess of
ardiac deaths should come from those who survived heart failure
nd died more than 5 years later. In our opinion, the authors could
urther analyze their patients who survived shorter or longer than
he median of 3 years to see the relationship between BMI  and
ortality.
In addition, the obesity-mortality paradox was initially
escribed in the bare-metal stent era before 2003 when most of
he registries were carried out in the western world.
In the drug-eluting stent-era, we conﬁrmed the obesity-
ortality paradox gradually attenuated among patients receiving
CI in a meta-analysis [3]. For Asian populations, there were
wo large-sized PCI cohorts conducted and followed up longer
han 2 years respectively in the drug-eluting stent era. In China,
ang et al. analyzed a cohort of 4972 patients treated with drug-
luting stents and the results showed that patients with overweight
BMI 25–29.9 kg/m2) and obesity (BMI ≥ 30 kg/m2) did not have
urvival beneﬁt compared to those with normal weight (BMI
8.5–24.9 kg/m2) [4]. In contrast, Park et al. reported the presence of
besity-mortality paradox in a 12,093 Korean PCI cohort with 82%
f patients using drug-eluting stents [5]. Since drug-eluting stents
ere found to affect the obesity-mortality paradox phenomenon,
he authors should clarify the use of drug-eluting stents in this
apanese cohort and examine the relation of BMI  to mortality in
atients with or without drug-eluting stents.
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